Abstract
Paradoxical worsening of tuberculosis associated with immune reconstitution during antiretroviral therapy in patients with HIV infection is known as the immune reconstitution inflammatory syndrome (IRIS). Here, we report a case of paradoxical worsening of IFN-alpha induced tuberculosis in a patient experiencing reconstitution of pathogen-specific immune responses after discontinuing TNFα antagonist therapy. This case serves to alert clinicians that complications such as tuberculosis may worsen after TNFα antagonist discontinuation. This situation may paradoxically require readministration of the immunosuppressive drug in some patients.
Copyright © 2011 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.
MeSH terms
-
Adalimumab
-
Aged
-
Anti-Inflammatory Agents / adverse effects*
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Antitubercular Agents / therapeutic use
-
Bronchoalveolar Lavage Fluid / microbiology
-
Drug Therapy, Combination
-
Female
-
Glucocorticoids / therapeutic use
-
Humans
-
Immune Reconstitution Inflammatory Syndrome / diagnosis*
-
Immune Reconstitution Inflammatory Syndrome / immunology
-
Latent Tuberculosis / diagnosis*
-
Latent Tuberculosis / drug therapy
-
Latent Tuberculosis / immunology
-
Mycobacterium tuberculosis / isolation & purification
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Withholding Treatment
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antitubercular Agents
-
Glucocorticoids
-
Tumor Necrosis Factor-alpha
-
Adalimumab